THE FOUNDATION FOR MEDICAL RESEARCH INFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV

Their core work

TASMC is the research foundation affiliated with Tel Aviv Sourasky Medical Center (Ichilov), one of Israel's largest and most prominent hospitals. They conduct clinical research spanning mental health, neuroscience, geriatric mobility, sleep medicine, and infectious disease management. Their H2020 participation focuses on contributing clinical cohorts and real-world patient data to large European health studies, bridging hospital-based clinical practice with multinational research initiatives. They bring particular strength in ambulatory patient monitoring and digital health outcome measurement.

What they specialise in

How they've shifted over time

TASMC's early H2020 work (2018-2019) centered on mental health, psychological resilience, and digital patient monitoring — using wearable sensors and ecological momentary assessment to track stress and mobility in real-world settings. Their more recent participation (2021 onward) shifted toward infectious disease, specifically antimicrobial resistance and hospital infection control. This evolution suggests a broadening from individual patient-level digital health toward hospital-system-level challenges.

TASMC is expanding from patient-centric digital health research into hospital-wide infection management and antimicrobial stewardship, signaling growing capacity in health systems research alongside their clinical expertise.

How they like to work

TASMC participates exclusively as a consortium partner, never as coordinator, which is typical for hospital-affiliated research foundations contributing clinical expertise and patient access to larger European studies. With 64 unique partners across 16 countries from just 4 projects, they operate in large, well-funded consortia. This makes them a reliable clinical site partner — they bring patients, data, and hospital infrastructure rather than project management overhead.

Despite only 4 projects, TASMC has built a broad network of 64 partners across 16 countries, reflecting participation in large multi-site clinical consortia. As an Israeli institution, they serve as a key non-EU associated country partner bringing Mediterranean and Middle Eastern clinical perspectives.

What sets them apart

TASMC offers something rare in European consortia: access to a major Israeli teaching hospital's clinical infrastructure, diverse patient populations, and a strong tradition of translational medical research. Their combination of digital health monitoring expertise with traditional clinical research makes them a versatile partner for projects needing real-world clinical validation. For consortium builders, they represent a trusted non-EU clinical site with established experience in multi-center European trials.

Highlights from their portfolio

• MOBILISE-D
  Largest project by far (EUR 1.1M to TASMC), a major EU initiative to validate digital mobility outcomes for regulatory endorsement — directly linking wearable sensor data to clinical decision-making.
• SleepEpisMemory
  ERC Consolidator Grant participation signals high scientific caliber; the project explores sleep-memory links with implications for dementia understanding.
• REVERSE
  Most recent project (2021), marks TASMC's entry into antimicrobial resistance — a top EU health priority — in high-prevalence clinical settings.